- Report
- February 2024
- 100 Pages
Global
From €3500EUR$4,186USD£3,088GBP
- Report
- May 2022
- 122 Pages
Global
From €3500EUR$4,186USD£3,088GBP
- Report
- March 2024
- 132 Pages
Global
From €851EUR$950USD£725GBP
Non-invasive prenatal testing (NIPT) is a type of prenatal screening used to detect chromosomal abnormalities in a fetus. It is a safe and accurate method of testing that does not involve any risk to the mother or fetus. NIPT is typically used to detect Down syndrome, trisomy 18, and trisomy 13, as well as other chromosomal abnormalities. It is also used to determine the sex of the fetus. NIPT is becoming increasingly popular as an alternative to traditional invasive prenatal testing, such as amniocentesis and chorionic villus sampling.
NIPT is offered by a variety of diagnostic companies, including Illumina, Natera, Ariosa Diagnostics, and Sequenom. These companies provide a range of services, from laboratory testing to genetic counseling. They also offer a variety of testing options, such as single-gene tests, whole-genome sequencing, and targeted sequencing. Show Less Read more